Regeneron Pharmaceuticals Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2006 | $42.2M | — | — |
| FY2007 | $49.8M | — | — |
| FY2008 | $238.5M | $-86.2M | $-79.1M |
| FY2009 | $383.7M | $-74.1M | $-67.8M |
| FY2010 | $457.8M | $-97.5M | $-104.5M |
| FY2011 | $445.8M | $-205.2M | $-221.8M |
| FY2012 | $1.38B | $457.7M | $750.3M |
| FY2013 | $2.11B | $743.1M | $413.7M |
| FY2014 | $2.82B | $823.9M | $338.1M |
| FY2015 | $4.10B | $1.25B | $636.1M |
| FY2016 | $4.86B | $1.33B | $895.5M |
| FY2017 | $5.87B | $2.08B | $1.20B |
| FY2018 | $5.15B | $2.53B | $2.44B |
| FY2019 | $6.56B | $2.21B | $2.12B |
| FY2020 | $8.50B | $3.58B | $3.51B |
| FY2021 | $16.07B | $8.95B | $8.08B |
| FY2022 | $12.17B | $4.74B | $4.34B |
| FY2023 | $13.12B | $4.05B | $3.95B |
| FY2024 | $14.21B | $3.99B | $4.41B |
| FY2025 | $14.34B | $3.58B | $4.50B |